Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Katherine P. Yates"'
Publikováno v:
PLoS ONE, Vol 11, Iss 6, p e0155634 (2016)
Prioritising biodiversity conservation requires knowledge of where biodiversity occurs. Such knowledge, however, is often lacking. New technologies for collecting biological and physical data coupled with advances in modelling techniques could help a
Externí odkaz:
https://doaj.org/article/c880969429d54a19bc4309fd292945ec
Autor:
Katherine L Yates, David S Schoeman
Publikováno v:
PLoS ONE, Vol 8, Iss 7, p e68424 (2013)
Spatial management tools, such as marine spatial planning and marine protected areas, are playing an increasingly important role in attempts to improve marine management and accommodate conflicting needs. Robust data are needed to inform decisions am
Externí odkaz:
https://doaj.org/article/bdc552b8c59c453dabd974ae346e1d39
Autor:
Katherine P Yates, Ross Deppe, Megan Comerford, Howard Masuoka, Oscar W Cummings, James Tonascia, Naga Chalasani, Raj Vuppalanchi, NASH CRN
Publikováno v:
PLoS ONE
PLoS ONE, Vol 12, Iss 11, p e0185813 (2017)
PLoS ONE, Vol 12, Iss 11, p e0185813 (2017)
Aim Serum high mobility group box 1 protein (HMGB1) is a proinflammatory molecule that could potentially serve as a biomarker for non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) due to its correlation with degree of
Autor:
Shaminie J. Athinarayanan, Wanqing Liu, Katherine P. Yates, Min Zhang, Naga Chalasani, Jean P. Molleston, Rongrong Wei, Shaochun Bai, Maret G. Traber, Oscar W. Cummings
Publikováno v:
PLoS ONE, Vol 9, Iss 4, p e95366 (2014)
PLoS ONE
PLoS ONE
Vitamin E improved liver histology in children and adults with NAFLD who participated in TONIC and PIVENS clinical trials, but with significant inter-individual variability in its efficacy. Cytochrome P450 4F2 (CYP4F2) is the major enzyme metabolizin